Hematology Testing Products Market Size Share and Industry Outlook to 2028

SKU: DMMD4141 | Last Updated On: Jan 20 2022 | No. of Pages: 180 | Available Formats

> Global Hematology Testing Products Market Expected to reach a high CAGR By 2028: DataM Intelligence.

Global Hematology Testing Products Market Is Segmented By Product Type Instruments Fully Automated Hematology Analyzers Semi-automated Hematology Analyzers Consumables Hematology Reagents Hematology Stains,  Others), By Type of Tests Complete Blood Count Analysis White Blood Cell Analysis Hemoglobin Test Bone Marrow Analysis Others), By End-User Hospitals Diagnostic Centers Research laboratories Bone Marrow Analysis Others), By Region (North America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028.
 
 

Market Overview

The global hematology testing products market is estimated to reach at a CAGR of 5.2 % during the forecast period (2021-2028). 

Hematology tests examine the blood, blood proteins, and organs that produce blood. Infection, anaemia, inflammation, haemophilia, blood-clotting problems, leukaemia, and the body's response to chemotherapy treatments are all illnesses that can be evaluated with these tests.

Source: DataM Intelligence Analysis (2020)

Market Dynamics

The factors driving the market growth of hematology testing products market are the technological advancements in the hematology analyzer and the increasing number of patients opting for blood tests.

Technological advancements in the hematology analyzer are expected to drive market growth in the forecast period

Hematology analyzers employ a variety of technologies to identify cell types in a blood sample and count them separately to provide a complete blood count (CBC) with differential. Internal cellular particles are stained with a fluorescent dye and the emitted light is captured, enzymatic properties of cells such as the presence of myeloperoxidase are used, and cellular volume is measured using direct current impedance (Coulter Principle). To separate cellular elements, some analyzers only have one histogram per module; however, modern analyzers can retrieve data from many histograms. This is achievable in analyzers that contain modern VCSn technology, which can collect multiple additional cellular metrics for each cell, including but not limited to five various angles of light scatter and pulse time, in addition to volume and conductivity. This data can be combined in a variety of ways to generate dozens of histograms per module, allowing distinct cellular constituents to be distinguished.

The VCS technology was primarily employed to generate the differential count in haematological analyzers that did not have this technology. The enhanced VCSn data is used across all analytical modules in newer analyzers, including the differential, reticulocyte, and nRBC modules, allowing the instrument to leverage this powerful technology to improve counting and detect many more important cellular elements, as well as provide an accurate and precise CBC-diff. Today's technical advancements in haematology analyzers provide the laboratory with more cellular information than was previously available through a basic routine CBC with differential. This new information can be used to improve cellular counting and reduce the number of unnecessary manual checks.

For example, On February 1st, 2021, Beckman Coulter launched, the DxH 560 AL which is a tabletop haematology analyzer developed to decrease the time and resource restrictions faced by small- to mid-sized laboratories. The DxH 560 AL produces results in less than 60 seconds. Because it only requires a 17-litre sample (less than a drop of blood), it can be utilised with difficult-to-draw patients (infants, cancer, and the elderly).

The increasing number of patients opting for blood tests is expected to drive the market growth

A review of clinical data from primary care that sheds insight on the frequency of blood test requests suggests the possibility for diagnostic platforms that integrate numerous commonly requested tests onto ‘multiplex' panels, potentially moving blood testing from laboratory settings to the community. The data revealed a variety of typical community-requested test combinations, including tests for a general health check and to explore anaemia, hormone levels, serum iron and vitamin levels, weariness, and renal and liver function, among more than 500 distinct blood tests examined.

Multiplex technologies have the potential to integrate numerous biochemical and haematological tests that may be performed in a short amount of time from a single blood sample, which is very useful when patients have a wide range of symptoms. Data from 11,763,473 laboratory blood tests requested by primary care practises in Oxfordshire for over 413,000 patients was analysed by a research team from the University of Oxford's Nuffield Department of Primary Care Health Sciences and the University of Leuven in Belgium to highlight the frequency and combination of tests requests in community settings.

Limitations of hematology testing are expected to hamper the market growth

Analytically and technically, haematology analyzers (HA) or automated blood cell counters are highly complicated automated analyzers. The total blood count is measured using these analyzers (CBC, also known as full blood count). The laboratory should only use HA that has been validated for the specified purpose, according to ISO 15189.  Validation, for example, according to CLSI recommendations, should be undertaken in principle by the manufacturer for the intended scope, and verification of the manufacturer's claim by the clinical laboratory is sufficient. Due to these validation requirements, many manufacturers face challenges. For example, some parameters must be compared to a standard way. Haematocrit, red blood cell count, white blood cell count, and white blood cell differential are just a few of the current reference systems. In such circumstances, the new method's increased performance is compared or calibrated to a relatively weak benchmark, resulting in a performance that is less analytically and technically realistic. Unfortunately, registration authorities in some countries require a comparison with these reference procedures and/or a current-generation analyzer. As a result, this requirement may result in less-than-optimal analytical performance and may also stifle innovation.

It has been difficult to obtain samples from healthy children and neonates. In the paediatric population, reference intervals are frequently based on publications from decades ago, using technology that is no longer widely available, making it unclear whether these reference ranges can be applied today; or new parameters or parameters are using a new analytical technique for which no published reference ranges are available. As a result, manufacturers should make significant efforts to develop reference intervals for their new HA in these populations.

COVID-19 Impact Analysis

COVID-19 has affected the healthcare industry moderately. To stop its spread, government-imposed lockdown. People are fearful they may experience occupational effects and negative health from the COVID-19 pandemic. The pandemic disrupted many diagnosis procedures, as well as the approvals. This has moderately affected the global hematology testing products market due to limitations to avoid transmission of COVID.

Segment Analysis

On basis of product type, hematology analyzer segment dominated the hematology testing products market

A full blood count (CBC) or hemogram is performed using a haematology analyzer (or haematology automaton). It analyses the blood's produced elements, including red blood cells (erythrocytes), white blood cells (leukocytes), and platelets, quantitatively and qualitatively (thrombocytes). It is primarily utilised in medical analysis laboratories or haematology units in hospitals. The recent technological advancements in the equipment are expected to increase the market growth. For example, the majority of haematology analyzers now include an integrated reticulocyte count analysis with the routine complete blood count analysis, which not only provides reticulocyte per cent and absolute reticulocyte counts, but also additional data such as reticulocyte haemoglobin content (CHr), per cent hypochromic cells, per cent microcytic cell or microcytic anaemia factor, immature reticulocyte fraction, and so on. The degree of hemoglobinization in maturing erythroid precursors is reflected by CHr, which is a measure of total haemoglobin content in a reticulocyte expressed in pg. Modern white cell analyzers provide a five to seven-part differential white cell analysis using various technologies such as electrical impedance, radiofrequency conductivity, light scatter, fluorescent scatter, and cytochemistry, among others. They also provide additional data in the form of cell population data (CPD) and Lymph Index (Beckman Coulter LH series analyzers using the volume, conductivity, and scatter [VCS] technology), Granularity Index (Sysmex XE series), and Large unstained cell population (Advia Systems) that can be used in the screening of benign and malignant haematological conditions.

On June 2nd,2021, Sysmex America, Inc., expanded its haematology portfolio with the FDA-cleared XN-10 Automated Hematology Analyzer with Blood Bank mode. The company is the first and only manufacturer of Automated Hematology devices that have FDA-approved intended use claims for the Blood Center/Blood Bank market. The XN Blood Bank mode is designed for QC release testing of post-processed components in blood processing centres.

Geographical Analysis

North America region accounted for the largest market share in the global hematology testing products market

The rising incidence of blood diseases and FDA approvals in this region is expected to dominate the global hematology testing products market. Most patients with haemophilia in the United States are diagnosed when they are very young. According to the Centers for Disease Control and Prevention, the median age at diagnosis for persons with mild haemophilia is 36 months, 8 months for those with moderate haemophilia, and 1 month for those with severe haemophilia. Anemia, infection, haemophilia, blood-clotting problems, and leukaemia can all be diagnosed with haematological tests. Hence, with the rising incidence of blood diseases, the demand for hematology testing is also estimated to increase the market growth.

On March 21st, 2019, Beckman Coulter, a global leader in clinical diagnostics, has obtained FDA 510(k) approval for their DxH 520 haematology analyzer which is now available for purchase in the United States.

Source: DataM Intelligence Analysis (2020)

Competitive Landscape

The global hematology testing products market is highly competitive with the rising number of diseases and technological advancements in diagnostics.

Some of the major key players in this market are Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Boule Diagnostics AB, Horiba, Ltd., Mindray Medical International Limited, Siemens Healthcare, Sysmex Corporation, Abbott Corelaboratory, Agappe Diagnostics and Bio way Biological Technology Co., Ltd.

Bio-Rad Laboratories

Overview: Bio-Rad is a global leader in the development, manufacture, and marketing of cutting-edge products for life science research and clinical diagnostics. Their products promote the discovery process and improve healthcare by focusing on quality and customer service for over 65 years. University and research institutions, hospitals, public health and commercial laboratories, biotechnology, and pharmaceutical laboratories, as well as applied laboratories such as food safety and environmental quality, are among their customers.

Product Portfolio: The company’s diagnostic products and systems are a major global provider of in-vitro diagnostics supplies, they use a wide range of technologies to give high-value clinical information in the blood transfusion, and infectious disease testing markets. For example, Liquichek Reticulocyte Control (X), Liquichek Reticulocyte Control (S) and Liquichek Reticulocyte Control (A-I) are some of their products.

Key Development: On 16th November 2020, Bio-Rad Laboratories, Inc. introduced new features for its D-10 Hemoglobin Testing System, which will help customers better manage patient results, improve quality control, and better align workflows and needs.

Why Purchase the Report?

  • Visualize the composition of the global hematology testing products market Segmentation by Product Type, by Type of Tests and End-User highlighting the key commercial assets and players.
  • Identify commercial opportunities in the global hematology testing products market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global hematology testing products market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global hematology testing products market report would provide access to an approx. 45+ market data table, 40+ figures and 180 pages. 

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Hematology Testing Products Market - By Product Type

  • Instruments
    • Fully Automated Hematology Analyzers
    • Semi-automated Hematology Analyzers
  • Consumables
    • Hematology Reagents
    • Hematology Stains
    • Others

Global Hematology Testing Products Market - By Type of Tests

  • Complete Blood Count Analysis
  • White Blood Cell Analysis
  • Hemoglobin Test
  • Bone Marrow Analysis
  • Others

Global Hematology Testing Products Market - By End-User

  • Hospitals
  • Diagnostic Centers
  • Research laboratories

Global Hematology Testing Products Market - By Region

  • North America
  • Europe
  • South America
  • Asia Pacific
  • Middle East and Africa

Trending Topics

Hematocrit Test Devices Market

Haemodialysis Equipment Market

Table of Contents

  1. Global Hematology Testing Products Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Hematology Testing Products Market – Market Definition and Overview

  3. Global Hematology Testing Products Market – Executive Summary

    1. Market Snippet By Product Type
    2. Market Snippet By Type of Tests
    3. Market Snippet By End-User
    4. Market Snippet By Region
  4. Global Hematology Testing Products Market -Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Technological advancements in the hematology analyzer
        2. Increasing number of patients opting for blood tests
      2. Restraints:
        1. Limitations of hematology testing
      3. Opportunity
      4. Impact Analysis
  5. Global Hematology Testing Products Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Epidemiology Analysis
    3. Supply Chain Analysis
    4. Pricing Analysis
    5. Regulatory Analysis
    6. Reimbursement Analysis
    7. Unmet Needs
  6. Global Hematology Testing Products Market – COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Global Hematology Testing Products Market – By Product Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
      2. Market Attractiveness Index, By Product Type Segment
    2. Instruments*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
      3. Fully Automated Hematology Analyzers
      4. Semi-automated Hematology Analyzers
    3. Consumables
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
      3. Hematology Reagents
      4. Hematology Stains
      5. Others
  8. Global Hematology Testing Products Market – By Type of Tests

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Tests
      2. Market Attractiveness Index, By Type of Tests
    2. Complete Blood Count Analysis*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. White Blood Cell Analysis
    4. Hemoglobin Test
    5. Bone Marrow Analysis
    6. Others
  9. Global Hematology Testing Products Market – By End-User

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
      2. Market Attractiveness Index, By End-User Segment
    2. Hospitals*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Diagnostic Centers
    4. Research laboratories
  10. Global Hematology Testing Products Market – By Region

    1. Introduction
      1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Tests
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Tests
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Tests
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Tests
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Tests
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  11. Global Hematology Testing Products Market – Competitive Landscape

    1. Key Developments and Strategies
    2. Company Share Analysis
    3. Product Benchmarking
  12. Global Hematology Testing Products Market - Company Profiles

    1. Bio-Rad Laboratories*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Beckman Coulter, Inc.
    3. Boule Diagnostics AB
    4. Horiba, Ltd.
    5. Mindray Medical International Limited
    6. Sysmex Corporatiom
    7. Siemens Healthcare
    8. Abbott Corelaboratory
    9. Agappe Diagnostics
    10. Bioway Biological Technology Co.,Ltd(*LIST NOT EXHAUSTIVE)
  13. Global Hematology Testing Products Market – DataM  

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

List of Tables

Table 01 Global Hematology Testing Products Market Value, By Product Type, 2020, 2024 & 2028($ Million)

Table 02 Global Hematology Testing Products Market Value, By Type of Tests, 2020, 2024 & 2028($ Million)

Table 03 Global Hematology Testing Products Market Value, By End-User, 2020, 2024 & 2028($ Million)

Table 04 Global Hematology Testing Products Market Value, By Product Type, 2020, 2024 & 2028($ Million)

Table 05 Global Hematology Testing Products Market Value, By Product Type, 2019-2028 ($ Million)

Table 06 Global Hematology Testing Products Market Value, By Type of Tests, 2020, 2024 & 2028($ Million)

Table 07 Global Hematology Testing Products Market Value, By Type of Tests, 2019-2028 ($ Million)

Table 08 Global Hematology Testing Products Market Value, By End-User, 2020, 2024 & 2028($ Million)

Table 09 Global Hematology Testing Products Market Value, By End-User, 2019-2028 ($ Million)

Table 10 Global Hematology Testing Products Market Value, By Region, 2020, 2024 & 2028($ Million)

Table 11  Global Hematology Testing Products Market Value, By Region, 2019-2028 ($ Million)

Table 12  North America Hematology Testing Products Market Value, By Product Type,2019-2028 ($ Million)

Table 13  North America Hematology Testing Products Market Value, By Type of Tests, 2019-2028 ($ Million)

Table 14  North America Hematology Testing Products Market Value, By End-User, 2019-2028 ($ Million)

Table 15  North America Hematology Testing Products Market Value, By Country, 2019-2028 ($ Million)

Table 16  South America Hematology Testing Products Market Value, By Product Type,2019-2028 ($ Million)

Table 17  South America Hematology Testing Products Market Value, By Type of Tests, 2019-2028 ($ Million)

Table 18 South America Hematology Testing Products Market Value, By End-User, 2019-2028 ($ Million)

Table 19  South America Hematology Testing Products Market Value, By Country, 2019-2028 ($ Million)

Table 20 Europe Hematology Testing Products Market Value, By Product Type,2019-2028 ($ Million)

Table 21  Europe Hematology Testing Products Market Value, By Type of Tests, 2019-2028 ($ Million)

Table 22 Europe Hematology Testing Products Market Value, By End-User, 2019-2028 ($ Million)

Table 23 Europe Hematology Testing Products Market Value, By Country, 2019-2028 ($ Million)

Table 24 Asia-Pacific Hematology Testing Products Market Value, By Product Type,2019-2028 ($ Million)

Table 25 Asia-Pacific Hematology Testing Products Market Value, By Type of Tests, 2019-2028 ($ Million)

Table 26 Asia-Pacific Hematology Testing Products Market Value, By End-User, 2019-2028 ($ Million)

Table 27 Asia-Pacific Hematology Testing Products Market Value, By Country, 2019-2028 ($ Million)

Table 28 Middle East & Africa Hematology Testing Products Market Value, By Product Type,2019-2028 ($ Million)

Table 29 Middle East & Africa Hematology Testing Products Market Value, By Type of Tests, 2019-2028 ($ Million)

Table 30 Middle East & Africa Hematology Testing Products Market Value, By End-User, 2019-2028 ($ Million)

Table 31  Bio-Rad Laboratories: Overview

Table 32 Bio-Rad Laboratories: Product Portfolio

Table 33 Bio-Rad Laboratories: Key Developments

Table 34 Beckman Coulter, Inc.: Overview

Table 35 Beckman Coulter, Inc.: Product Portfolio

Table 36 Beckman Coulter, Inc.: Key Developments

Table 37 Boule Diagnostics AB: Overview

Table 38 Boule Diagnostics AB: Product Portfolio

Table 39 Boule Diagnostics AB: Key Developments

Table 40 Horiba, Ltd.: Overview

Table 41  Horiba, Ltd.: Product Portfolio

Table 42 Horiba, Ltd.: Key Developments

Table 43 Mindray Medical International Limited: Overview

Table 44 Mindray Medical International Limited: Product Portfolio

Table 45 Mindray Medical International Limited: Key Developments

Table 46 Sysmex Corporation: Overview

Table 47 Sysmex Corporation: Product Portfolio

Table 48 Sysmex Corporation: Key Developments

Table 49 Siemens Healthcare Overview

Table 50 Siemens Healthcare: Product Portfolio

Table 51  Siemens Healthcare: Key Developments

Table 52 Abbott Corelaboratory: Overview

Table 53 Abbott Corelaboratory: Product Portfolio

Table 54 Abbott Corelaboratory: Key Developments

Table 55 Agappe Diagnostics: Overview

Table 56 Agappe Diagnostics: Product Portfolio

Table 57 Agappe Diagnostics: Key Developments

Table 58 Bioway Biological Technology Co.,Ltd: Overview

Table 59 Bioway Biological Technology Co.,Ltd: Product Portfolio

Table 60 Bioway Biological Technology Co.,Ltd: Key Developments

List of Figures

Figure 01  Global Hematology Testing Products Market Share, By Product Type, 2020 & 2028(%)

Figure 02 Global Hematology Testing Products Market Share, By Type of Tests, 2020 & 2028(%)

Figure 03 Global Hematology Testing Products Market Share, By End-User, 2020 & 2028(%)

Figure 04 Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 05 Global Hematology Testing Products Market Y-o-Y Growth, By Product Type, 2020-2028 (%)

Figure 06 Instruments: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 07 Consumables: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 08 Global Hematology Testing Products Market Y-o-Y Growth, By Type of Tests, 2020-2028 (%)

Figure 09 Complete Blood Count Analysis: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 10  White Blood Cell Analysis: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 11  Hemoglobin Test: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 12  Bone Marrow Analysis: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 13  Others: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 14  Global Hematology Testing Products Market Y-o-Y Growth, By End-User, 2020-2028 (%)

Figure 15  Hospitals: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 16  Diagnostic Centers: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 17  Research laboratories: Global Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 18  Global Hematology Testing Products Market Y-o-Y Growth, By Region, 2020-2028 (%)

Figure 19  North America Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 20 North America Hematology Testing Products Market Share, By Product Type, 2020 & 2028(%)

Figure 21  North America Hematology Testing Products Market Share, By Type of Tests, 2020 & 2028(%)

Figure 22 North America Hematology Testing Products Market Share, By End-User, 2020 & 2028(%)

Figure 23 North America Hematology Testing Products Market Share, By Country, 2020 & 2028(%)

Figure 24 South America Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 25 South America Hematology Testing Products Market Share, By Product Type, 2020 & 2028(%)

Figure 26 South America Hematology Testing Products Market Share, By Type of Tests, 2020 & 2028(%)

Figure 27  South America Hematology Testing Products Market Share, By End-User, 2020 & 2028(%)

Figure 28 South America Hematology Testing Products Market Share, By Country, 2020 & 2028(%)

Figure 29 Europe Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 30 Europe Hematology Testing Products Market Share, By Product Type, 2020 & 2028(%)

Figure 31  Europe Hematology Testing Products Market Share, By Type of Tests, 2020 & 2028(%)

Figure 32 Europe Hematology Testing Products Market Share, By End-User, 2020 & 2028(%)

Figure 33 Europe Hematology Testing Products Market Share, By Country, 2020 & 2028(%)

Figure 34 Asia-Pacific Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 35 Asia-Pacific Hematology Testing Products Market Share, By Product Type, 2020 & 2028(%)

Figure 36 Asia-Pacific Hematology Testing Products Market Share, By Type of Tests, 2020 & 2028(%)

Figure 37  Asia-Pacific Hematology Testing Products Market Share, By End-User, 2020 & 2028(%)

Figure 38 Asia-Pacific Hematology Testing Products Market Share, By Country, 2020 & 2028(%)

Figure 39 Middle East & Africa Hematology Testing Products Market Value, 2019-2028 ($ Million)

Figure 40 Middle East & Africa Hematology Testing Products Market Share, By Product Type, 2020 & 2028(%)

Figure 41  Middle East & Africa Hematology Testing Products Market Share, By Type of Tests, 2020 & 2028(%)

Figure 42 Middle East & Africa Hematology Testing Products Market Share, By End-User, 2020 & 2028(%)

Figure 43 Bio-Rad Laboratories: Financials

Figure 44 Beckman Coulter, Inc.: Financials

Figure 45 Boule Diagnostics AB: Financials

Figure 46 Horiba, Ltd.: Financials

Figure 47  Mindray Medical International Limited: Financials

Figure 48 Sysmex Corporation: Financials

Figure 49 Siemens Healthcare:Financials

Figure 50 Abbott Corelaboratory: Financials

Figure 51  Agappe Diagnostics: Financials

Figure 52 Bioway Biological Technology Co.,Ltd: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest